Human medicines European public assessment report (EPAR): Galafold, migalastat, Date of authorisation: 25/05/2016, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Rotarix, rotavirus vaccine, live, Date of authorisation: 21/02/2006, Revision: 43, Status: Authorised

Questions and answers on the outcome of assessment on use of Revolade in treatment of severe aplastic anaemia in children

New product information wording: extracts from PRAC recommendations on signals adopted at the 7-10 July 2025 PRAC

Human medicines European public assessment report (EPAR): Piqray, alpelisib, Date of authorisation: 27/07/2020, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Fanskya, Mozafancogene autotemcel, Status: Application withdrawn

Human medicines European public assessment report (EPAR): Oczyesa, octreotide, Date of authorisation: 30/06/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 57, Status: Authorised

Human medicines European public assessment report (EPAR): Vimkunya, Chikungunya vaccine (recombinant, adsorbed), Date of authorisation: 28/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Ninlaro, ixazomib, Date of authorisation: 21/11/2016, Revision: 20, Status: Authorised